SunMed to Acquire Avanos Medical's Respiratory Health Business - Avanos Medical (NYSE:AVNS)
Benzinga Strengthens portfolio with market-defining BALLARD*, MICROCUFF* and endOclear brands
Enhances position as premier, completely dedicated consumable breathing products company
Provides expanded North American manufacturing footprint and innovation expertise
SunMed, a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care, today announced it has entered into a definitive agreement with Avanos Medical, Inc. AVNS ("Avanos"), under which SunMed will acquire Avanos' respiratory health business, including the BALLARD*, MICROCUFF* and endOclear product lines. This combination further expands the breadth of SunMed's leading product offering, providing customers with a one-stop source for the most trusted and highest-quality brands in anesthesia and respiratory care, which support the best outcomes for patients.
Through the transaction, SunMed is adding market leading brands to its expansive and growing portfolio, providing healthcare providers and patients with even more options. The BALLARD*, MICROCUFF* and endOclear brands include closed suction catheters, endotracheal tubes and oral care solutions, whose products have achieved strong trust, recognition and respect among healthcare providers around the world for their high quality and advanced technology. Included in the transaction, in addition to expanding its product lines with these respiratory consumables, SunMed is acquiring two Avanos manufacturing facilities in Mexico and R&D expertise that support these brands.
